Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? S. M. Marshall Then and Now 14 June 2012 Pages: 2301 - 2306
Low HbA1c and mortality: causation and confounding M. K. Rutter Commentary 18 July 2012 Pages: 2307 - 2311
A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucose transport into the human beta cell M. van de BuntA. L. Gloyn Commentary 15 June 2012 Pages: 2312 - 2315
A new view of the beta cell J. Ahnfelt-RønneJ. Hecksher-SørensenO. D. Madsen Commentary 18 July 2012 Pages: 2316 - 2318
Adiponectin: mechanistic insights and clinical implications A. T. TurerP. E. Scherer Review 12 June 2012 Pages: 2319 - 2326
Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989–2008 M. KlemettiM. NuutilaK. Teramo Article 03 July 2012 Pages: 2327 - 2334
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland H. C. LookerS. O. Nyangomaon behalf of the Scottish Diabetic Retinopathy Screening Collaborative and the Scottish Diabetes Research Network Epidemiology Group Article Open access 12 June 2012 Pages: 2335 - 2342
Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers T. E. AdrianS. GariballaA. A. Young Short Communication 14 June 2012 Pages: 2343 - 2347
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes C. AnderssonL. van GaalC. Torp-Pedersen Article 26 May 2012 Pages: 2348 - 2355
The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes L. GovanE. Maiettion behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group* Short Communication 26 June 2012 Pages: 2356 - 2360
Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study M. V. SkriverH. StøvringA. Sandbæk Article 27 June 2012 Pages: 2361 - 2370
Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study J. G. DreyfusP. L. LutseyE. W. Demerath Article 04 July 2012 Pages: 2371 - 2380
SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion F. H. SansburyS. E. FlanaganA. T. Hattersley Short Communication 02 June 2012 Pages: 2381 - 2385
SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes E. FagerholmE. Ahlqviston behalf of the FinnDiane Study Group Article 29 May 2012 Pages: 2386 - 2393
Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations A. M. ValdesH. A. ErlichJ. A. Noble Article 17 June 2012 Pages: 2394 - 2401
KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes X. L. LimS. NurbayaD. P. K. Ng Article 14 June 2012 Pages: 2402 - 2406
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27) D. VatsH. WangM. Rudin ARTICLE Open access 13 July 2012 Pages: 2407 - 2416
Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes I. MarhfourX. M. LopezD. L. Eizirik Short Communication 15 June 2012 Pages: 2417 - 2420
Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children M. LundhD. P. ChristensenT. Mandrup-Poulsen Article 07 July 2012 Pages: 2421 - 2431
Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour C. BeallD. L. HamiltonM. L. J. Ashford Article Open access 04 July 2012 Pages: 2432 - 2444
Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion H. E. ParkerA. AdriaenssensF. M. Gribble Article Open access 26 May 2012 Pages: 2445 - 2455
Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes Y.-S. LeeM.-S. ParkH.-S. Jun Article 22 June 2012 Pages: 2456 - 2468
Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice M. González-GranilloK. R. SteffensenA. R. Tovar Article 29 June 2012 Pages: 2469 - 2478
No evidence of enteroviruses in the intestine of patients with type 1 diabetes A. MercalliV. LampasonaL. Piemonti Article 10 June 2012 Pages: 2479 - 2488
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study J. W. M. NinI. FerreiraC. D. A. Stehouwer Short Communication Open access 01 July 2012 Pages: 2489 - 2493
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin S. MasiR. LautamäkiP. Iozzo Article 01 July 2012 Pages: 2494 - 2500
Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers J. van ArkJ. MoserJ. L. Hillebrands Article Open access 01 June 2012 Pages: 2501 - 2512
Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models H. LowA. HoangD. Sviridov Article 10 May 2012 Pages: 2513 - 2521
Deletion of p47 phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse G. C. LiuF. FangJ. W. Scholey Article 01 June 2012 Pages: 2522 - 2532
Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes Y. ChenJ. J. WangS. X. Zhang Article 04 June 2012 Pages: 2533 - 2545
Diabetes and amputation: don’t forget outcomes P. W. MoxeyR. J. HinchliffeP. J. E. Holt Letter 27 June 2012 Pages: 2546 - 2546
Renoprotective effects of renin–angiotensin–aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis F. Catalá-López Letter 23 June 2012 Pages: 2547 - 2548
Renoprotective effects of renin–angiotensin–aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis. Reply to Catalá-López F [letter] P. VejakamaA. ThakkinstianJ. Attia Letter 30 June 2012 Pages: 2549 - 2550